Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2026-03-06 @ 2:40 AM
Study NCT ID:
NCT00875433
Status:
COMPLETED
Last Update Posted:
2013-12-30
First Post:
2009-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-04-02
First Submit QC Date:
None
Study First Post Date:
2009-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-08
Results First Submit QC Date:
None
Results First Post Date:
2013-11-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-12-05
Last Update Post Date:
2013-12-30
Last Update Post Date Type:
ESTIMATED